SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-004515
Filing Date
2020-05-07
Accepted
2020-05-07 07:17:28
Documents
2
Period of Report
2020-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_050520.htm 8-K 32588
2 PRESS RELEASE DATED MAY 7, 2020, ISSUED BY THE COMPANY ex99-01.htm EX-99.01 16927
  Complete submission text file 0001387131-20-004515.txt   50770
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20854556
SIC: 2834 Pharmaceutical Preparations